BSE filing, NSE: SRTL. Summary written from the filing by ALFA Finder's alert engine.
Shree Ram Twistex Ltd: key numbers
- Share price
- ₹33.60
- Market cap
- ₹134.3 Cr
- Revenue (annual)
- ₹272.9 Cr
- Net profit (annual)
- ₹14.17 Cr
- P/E (TTM)
- 8.7×Sector 50.0×
- Promoter holding
- 34.59%+0.00% QoQ
- FII holding
- 2.80%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Shree Ram Twistex Ltd
All →Shree Ram Twistex Other Announcement
Shree Ram Twistex filed its IPO proceeds monitoring report for the quarter ended September 30, 2026. Utilisation deviates up to 10% from offer objects, shareholder-approved.
Shree Ram Twistex Board Meeting Date
Shree Ram Twistex Ltd has scheduled its Board of Directors meeting for 30 October 2026. The sole agenda item is approval of the draft Monitoring Agency Report for Q1 FY27.
Shree Ram Twistex Q2 FY27 Results: Net Profit ₹4.7 Cr, Up 30.6% YoY
Shree Ram Twistex Ltd reported revenue from operations of ₹136 Cr (+97.7% YoY) and net profit of ₹4.7 Cr (+30.6% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.7 Cr · +30.6% YoY
Shree Ram Twistex Other Announcement
This is a routine quarterly shareholding pattern filing for Shree Ram Twistex Ltd. It is submitted in compliance with SEBI Regulation 31(1)(b).
Shree Ram Twistex Board Meeting Date
Shree Ram Twistex will hold a board meeting on October 20, 2026 to approve H1 FY27 results. No financial figures are disclosed at this stage.
Shree Ram Twistex Annual General Meeting
Shree Ram Twistex Limited held its 13th Annual General Meeting on September 24, 2026. The meeting discussed financial statements, director re-appointment, and cost auditor remuneration ratification.
Other fund raise announcements
All →Rite Zone Chemcon India Fund Raise of ₹6.58 Cr
Rite Zone Chemcon India announced a preferential issue of 27,69,730 equity shares to 11 investors at Rs.24 each, raising about Rs.6.58 Crore. The approval awaits a shareholder vote on 23 November 2026.
- Value
- ₹6.58 Cr
Sudarshan Pharma Industries Fund Raise of ₹72 Cr
Sudarshan Pharma's board approved up to Rs. 72 Crore of preferential convertible warrants for promoters Hemal and Sachin Mehta. Shareholder approval will be sought at an EGM.
- Value
- ₹72.00 Cr
Flywings Simulator Training Centre Fund Raise of ₹68.2 Cr
Flywings Simulator's board approved Rs. 68.20 Crore fully convertible warrants on a preferential basis. Promoter Rupal Mandavia is allotted Rs. 25 Crore, subject to shareholder approval.
- Value
- ₹68.20 Cr
Kanel Industries Fund Raise of ₹16.99 Cr
Kanel Industries' board approved a rights issue of 42.52 lakh equity shares at Rs.39.95 each. The issue aggregates about Rs.16.99 Crore, with record date 13 November 2026.
- Value
- ₹16.99 Cr
- Execution
- Rights issue opens 23 November 2026 and closes 30 November 2026
Sudarshan Pharma Industries Fund Raise
Board approved issuing up to 72 Crore warrants to promoters on a preferential basis. Pricing per Reg 164 is pending, with no fixed rupee value stated.
GAIL (India) Fund Raise
GAIL Board approved in principle the IPO of subsidiary GAIL Gas Limited on Indian exchanges. GAIL will dilute its GGL equity up to 25%.